4 results
Keyword Leustatin Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Litak
Cladribine, Leukemia, Hairy Cell
Date of authorisation: 14/04/2004, Revision: 7, Authorised, Last updated: 04/04/2018 -
List item
Human medicine European public assessment report (EPAR): Mavenclad
Cladribine, Multiple Sclerosis
Date of authorisation: 22/08/2017, Revision: 8, Authorised, Last updated: 10/05/2022 -
List item
Withdrawn application: Movectro
cladribine, date of withdrawal: 08/02/2011, Initial authorisation, Last updated: 23/02/2011 -
List item
Public data from Article 57 database
Last updated: 17/10/2022